Medical Support to Light Footprint Operations
Why smaller operations require a different approach to medical support
ResearchPublished Jun 9, 2017
Light Footprint Operations (LFO) is a concept not currently found in EU doctrine, despite many EU military missions being small in size and shorter in duration. This study, commissioned by the European Defence Agency, defines LFO and its impact on required medical support. The report provides recommendations on doctrine, harmonisation and standardisation, modularisation of roles, multinational cooperation and engagement with civilian medicine.
Why smaller operations require a different approach to medical support
ResearchPublished Jun 9, 2017
Light Footprint Operations (LFO) is a concept not currently found in EU doctrine, despite a number of recent EU military missions being characterised as: involving a limited number of personnel deployed with no host nation support; seeking to leave small infrastructure footprint; being relatively short. Whilst so far all EU missions without host nation support have deployed medical support for more traditionally defined medical capabilities (Role 1 and Role 2 medical treatment facilities (MTFs)), these capabilities are designed to support larger military formations in both permissive and hostile operating environments.
This study was carried out in support to the European Defence Agency's work to achieve more efficient medical support to LFO carried out as part of the EU Common Security and Defence Policy (CSDP). A selection of methodologies was employed, including concept development, case study analysis, literature reviews, interviews, expert workshop, survey on European medical support capabilities and attitudes towards multinational cooperation and harmonisation, scenario development, medical technology scan and feasibility assessments. The study proposes a definition for LFO and concludes with a set of recommendations on current doctrine, harmonisation and standardisation, modularisation of Roles, multinational cooperation in technology development and deployment and engagement with civilian medical community.
The research described in this report was prepared for the European Defence Agency and conducted by RAND Europe.
This publication is part of the RAND research report series. Research reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND research reports undergo rigorous peer review to ensure high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.